COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,554 Articles (22,400 medRxiv, 8,154 bioRxiv)

Most recent first Previous |  Page 2567: Articles 25661-25670  | Next

Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression
Wu, C., Ye, D., Mullick, A. E., Li, Z., Daugherty, A., Lu, H. S.
10.1101/2020.06.08.137331 — Posted: 2020-06-08
SARS-CoV-2 Whole Genome Amplification and Sequencing for Effective Population-Based Surveillance and Control of Viral Transmission
Harilal, D., Ramaswamy, S., Loney, T., Varghese, R., Deesi, Z., Nowotny, N., Alsheikh-Ali, A., Abou Tayoun, A.
10.1101/2020.06.06.138339 — Posted: 2020-06-08 Discussion: Onsite
Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike
Prevost, J., Gasser, R., Beaudoin-Bussieres, G., Richard, J., Duerr, R., Laumaea, A., Anand, S. P., Goyette, G., Ding, S., Medjahed, H., Lewin, A., Perreault, J., Tremblay, T., Gendron-Lepage, G., Gauthier, N., Carrier, M., Marcoux, D., Piche, A., Lavoie, M., Benoit, A., Loungnarath, V., Brochu, G., Desforges, M., Talbot, P. J., Gould Maule, G. T., Cote, M., Therrien, C., Serhir, B., Bazin, R., Roger, M., Finzi, A.
10.1101/2020.06.08.140244 — Posted: 2020-06-08
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Tandon, R., Sharp, J. S., Zhang, F., Pomin, V. H., Ashpole, N. M., Mitra, D., Jin, W., Liu, H., Sharma, P., Linhardt, R. J.
10.1101/2020.06.08.140236 — Posted: 2020-06-08
SARS-CoV-2-specific T cells exhibit unique features characterized by robust helper function, lack of terminal differentiation, and high proliferative potential
Neidleman, J., Luo, X., Frouard, J., Xie, G., Gurjot, G., Stein, E. S., McGregor, M., Ma, T., George, A., Kosters, A., Greene, W. C., Vasquez, J., Ghosn, E., Lee, S., Roan, N. R.
10.1101/2020.06.08.138826 — Posted: 2020-06-08 Discussion: Onsite | Offsite
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.
Dong, T., Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Turtle, L., Rostron, T., Subramaniam, K., Thomson, P., Zhang, P., Dold, C., Ratcliff, J., de Silva, T., Sopp, P., Wellington, D., Rajapaksa, U., Paes, W., Borrow, P., Kessler, B. M., Fry, J. W., Schwabe, N. F., Semple, M. G., Baillie, J. K., Openshaw, P. J., Cornall, R. J., Conlon, C., Screaton, G., Klenerman, P., Mongkolsapaya, J., McMichael, A., Knight, J. C., Ogg, G., Simmonds, P., Lockett, T., Levin, R., Moore, S. C., Salio, M., Napolitani, G., Chen, Y.-L., Dunachie, S., Supasa, P., Liu, C., Lopez-Camacho, C., Slon-Campos, J., Zhao, Y., Stuart, D. I., Paeson, G., Grimes, J., Antson, F., Bayfield, O. W., Hawkins, D. E., Ker, D.-S., Ansari, A., Barnes, E., Frater, J., Kerr, G., Goulder, P.
10.1101/2020.06.05.134551 — Posted: 2020-06-08 Discussion: Onsite
Structure Basis for Inhibition of SARS-CoV-2 by the Feline Drug GC376
Luan, X., Shang, W., Wang, Y., Yin, W., Jiang, Y., Feng, S., Wang, Y., Liu, M., Zhou, R., Zhang, Z., Wang, F., Wang, C., Gao, M., Wang, H., Wu, W., Tian, R., Tian, Z., Jin, Y., Jiang, H., Zhang, L., Xu, H. E., Zhang, S.
10.1101/2020.06.07.138677 — Posted: 2020-06-08
Laboratory findings in coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis
Karimian, M., Jamshidbeigi, A., Badfar, G., Azami, M.
10.1101/2020.06.07.20124602 — Posted: 2020-06-08
Predictors of Mental Health during the early Covid-19 Pandemic in the US: role of economic concerns, health worries and social distancing
Kampfen, F., Kohler, I. V., Ciancio, A., de Bruin, W. B., Maurer, J., Kohler, H.-P.
10.1101/2020.06.06.20124198 — Posted: 2020-06-08
A scaling approach to estimate the COVID-19 infection fatality ratio from incomplete data
Seoane, B.
10.1101/2020.06.05.20123646 — Posted: 2020-06-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).